Spotlight on global cancer control at ASCO 2022

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

Pembrolizumab demonstrates clinically meaningful improvement in distant metastasis-free survival in patients with melanoma

Neoadjuvant ipilimumab and nivolumab immunotherapy could become new standard of care for resectable stage III melanoma

Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A retrospective analysis of 104 patients

Giving abatacept after checkpoint inhibitors can improve immunotherapy responses in melanoma

Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refractory to anti-PD-1 therapy

OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO

OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more

Significance of gut microbiota in patients receiving CAR T cell immunotherapy

Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal mucosal melanoma

KEYNOTE-716: Adjuvant pembrolizumab prolongs recurrence-free survival in resected stage II melanoma